Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Kanaoka H, Nagahashi M, Atake Y, Hattori A, Bun A, Fukui R, Ozawa H, Fujimoto Y, Higuchi T, Natori K, Imamura M, Murase K, Takatsuka Y, Miyoshi Y. Kanaoka H, et al. Among authors: takatsuka y. Anticancer Res. 2022 Oct;42(10):4867-4878. doi: 10.21873/anticanres.15992. Anticancer Res. 2022. PMID: 36192009
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
Miyagawa Y, Araki K, Bun A, Ozawa H, Fujimoto Y, Higuchi T, Nishimukai A, Kira A, Imamura M, Takatsuka Y, Miyoshi Y. Miyagawa Y, et al. Among authors: takatsuka y. Clin Breast Cancer. 2018 Oct;18(5):400-409. doi: 10.1016/j.clbc.2018.03.002. Epub 2018 Mar 8. Clin Breast Cancer. 2018. PMID: 29605174 Free article.
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.
Miyagawa Y, Miyake T, Yanai A, Murase K, Imamura M, Ichii S, Takatsuka Y, Ito T, Hirota S, Saito M, Kotoura Y, Miyauchi K, Fujimoto Y, Hatada T, Sasa M, Miyoshi Y. Miyagawa Y, et al. Among authors: takatsuka y. Breast Cancer. 2015 Jul;22(4):399-405. doi: 10.1007/s12282-013-0493-z. Epub 2013 Sep 3. Breast Cancer. 2015. PMID: 24000037
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A, Yagi T, Yanai A, Miyagawa Y, Enomoto Y, Murase K, Imamura M, Takatsuka Y, Sakita I, Hatada T, Miyoshi Y. Nishimukai A, et al. Among authors: takatsuka y. Clin Breast Cancer. 2015 Jun;15(3):204-11. doi: 10.1016/j.clbc.2014.12.007. Epub 2014 Dec 24. Clin Breast Cancer. 2015. PMID: 25600243
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Imamura M, Nishimukai A, Higuchi T, Ozawa H, Yanai A, Miyagawa Y, Murase K, Sakita I, Hatada T, Takatsuka Y, Katagiri T, Miyoshi Y. Imamura M, et al. Among authors: takatsuka y. Breast Cancer Res Treat. 2015 Dec;154(3):521-31. doi: 10.1007/s10549-015-3638-2. Epub 2015 Nov 16. Breast Cancer Res Treat. 2015. PMID: 26573829
312 results